Scholars Central

Review articlePublished 25 Oct 2023

A Systemic Review on Aducanumab and Lecanamab in the Development of ARIA in Alzheimer's Disease

Authors: Ankit Verma, Roshi, Priyanshi Sharma, Priyanka Saroj

Journal of Clinical & Experimental Pharmacology

Volume 13 · Issue 6 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Alzheimer's is a condition of neurodegenerative disease, which caused cognitive and memory loss in the patient. The condition usually progresses in those over 65, and it causes dementia to develop along with memory loss and impairments in cognitive behavior. By 2050, there will be 113 million cases of dementia worldwide, up from the 50 million cases there were in 2010. Amyloid plaques and neurofibrillary tangles are the major cause of AD. Formation of Aβ associated with the conversion of APP protein into Aβ through γ-secretase enzyme and formation of neurotangillary fibre are associated with hyperphosphorylation of tau protein. Disease modifying therapy like aducanumab, bapineuzumab, gantenerumab, donanemab, crenezumab, solanezumab and lecanamab are developed. It is believed that these Anti Aβ antibodies are very significantly reduce the level of Aβ. Aducanumab and lecanamab showing good therapeutic effect with lesser degree of side effect. ARIA-A and ARIA-H are most commonly associated side effect of these anti Aβ antibody. In this review we are focused on the comparison between Aducanumab and lecanamab, their mechanism of reducing Aβ level, binding profile with soluble and insoluble plaque and their side effect.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical & Experimental Pharmacology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Pharmacology
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ankit Verma”
  • BylineArticles whose byline prints “Roshi”
  • BylineArticles whose byline prints “Priyanshi Sharma”
  • BylineArticles whose byline prints “Priyanka Saroj”